$VCEL

Vericel Corp

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Burlington, MA

VCEL chart

What traders are saying about $VCEL

Latest posts

Vericel Corp news

Vericel Corp key financials

USD2025202420232022
Revenue$276.3M$237.2M$197.5M$163.7M
Net income$16.5M$10.4M-$3.2M-$16.7M
Diluted EPS$0.32$0.20$-0.07$-0.35
Total assets (year end)$488.0M$432.7M$353.7M$273.0M
Cash and equivalents (year end)$100.1M$74.5M$69.1M$51.1M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Vericel Corp

Ticker
VCEL (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Burlington, MA
Incorporated in
MI
Fiscal year end
December 31
SEC CIK
887359
Former names
AASTROM BIOSCIENCES INC

Frequently asked questions

What exchange is Vericel Corp listed on?

Vericel Corp trades on the Nasdaq under the ticker symbol VCEL.

What industry is Vericel Corp in?

Vericel Corp is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Vericel Corp headquartered?

Vericel Corp's business address on file with the SEC is in Burlington, MA.

When does Vericel Corp's fiscal year end?

Vericel Corp's fiscal year ends on December 31.

How much revenue did Vericel Corp report?

Vericel Corp reported $276.3M in revenue for calendar year 2025, according to its SEC filings.